CREO

Why do some products soar post-launch while others stall? Perhaps your groundbreaking medical device had strong pre-launch momentum but struggled to gain traction in the first six months. You’re not alone—this challenge is more common than you’d think. In CREO's recent article, Akira Robinson breaks down key insights from real-world case studies and successful life sciences product launches to share: ✅ The key effectiveness indicators that predict post-launch success ✅ How to anticipate and counter competitor responses ✅ The post-launch strategy shifts that make or break a product Visit 🔗 https://lnkd.in/e86BhvBu for the full article What's been the biggest post-launch challenge you've faced? Share your thoughts in the comments below! 👇 #ProductLaunch #LifeSciences #Strategy #Healthcare #PostLaunch #GoToMarket #Agility #LaunchStrategy

Did you miss yesterday’s M&A roundtable? No problem, you can catch it on demand via the link or QR code! 📺🔗https://lnkd.in/eG4qb6GP Our expert panel covered key topics including: ✔️ How economic and policy changes are influencing deals ✔️ The evolving role of private equity in life sciences and healthcare ✔️ Key challenges in business sales and integration ✔️ Why cultural alignment and communication matter more than ever What has stood out to you in the M&A space recently? Let us know in the comments! #MergersAndAcquisitions #MA #LifeSciences #Healthcare #PrivateEquity #CREO #Roundtable #Webinar Thanks again to our moderator Jim McCusker and the panelists for their collaboration: Jake Curtis (Bourne Partners), Harry Fisk (AmeriPro Health), David Fitzgerald (Petra Capital Partners), Jeanne Hecht (Lexitas Pharma Services), and CREO's own David Stuart.

⏰ TODAY’s the day! Don’t miss out on this exclusive opportunity to hear from industry leaders about the forces driving M&A activity in 2025. 🔎 Join us at 2 PM EST for our live roundtable, "What’s Next for M&A in 2025: Economic and Policy Drivers," where experts in finance, life sciences, and healthcare will break down the trends shaping dealmaking and provide valuable insights to help you stay ahead. 📅 2 PM EST TODAY—February 13 ⏳ There’s still time to register! Follow the link or scan the QR code below to secure your spot before it’s too late ➡️ https://lnkd.in/eYk3xs9W We look forward to seeing you there! #MergersAndAcquisitions #MA #BusinessGrowth #Leadership #Webinar #LifeSciences #Healthcare #Consulting #CREO

🔎 Cut through the uncertainty—join us tomorrow for expert insights on the key drivers of M&A activity in 2025. 📊 Market shifts, economic pressures, and policy changes are redefining how deals are made. Join our roundtable, "What's Next for M&A in 2025: Economic and Policy Drivers," to hear from industry experts as they break down emerging trends and provide the clarity you need to stay ahead in 2025 and beyond. 📅 February 13 at 2 PM EST ⏳ Time is running out! Secure your spot now via the QR code or this link ➡️ https://lnkd.in/eYk3xs9W Thank you to our panelists for lending their expertise to this important conversation! #MergersAndAcquisitions #MA #BusinessGrowth #2025Predictions #Leadership #Webinar #LifeSciences #Healthcare #Consulting #CREO

How do you turn deep expertise into real business impact? That was a core topic explored in yesterday's Lunch & Learn. CREO's Parker Moss, Bob Riefer, and Noah Rosenberg led a great session on creating clarity in complex situations and uncovering the real challenges behind client needs. A few key takeaways: 💡 Clarity fuels action – Breaking down complexity into a clear story empowers teams to move forward with confidence and communicate their value effectively. 💡 A great value proposition isn’t just about outlining what you do, it’s about framing its impact. 💡 The real problem that needs solving is rarely the first one presented. Digging deeper builds trust and leads to meaningful change. 💡 Driving change goes beyond sharing knowledge. It’s about building authentic relationships, knowing when to push versus when to hold back, and shaping conversations that drive results. It’s always valuable to step back and reflect on the thinking behind the work we do. Looking forward to our next Lunch & Learn! #Consulting #Strategy #Leadership #DecisionMaking #TrustedAdvisor #LifeSciences #ChangeManagement #ValueProposition #LunchAndLearn

📢 Only 3 days left to secure your spot! Join us for "What's Next for M&A in 2025: Economic and Policy Drivers," a must-attend virtual roundtable featuring leaders in life sciences and healthcare. Market uncertainty and shifting policies will continue to shape dealmaking—this expert-led discussion will provide the insights you need to stay ahead in 2025 and beyond. Don't miss this opportunity to have your questions answered and break down emerging trends. 📅 February 13 at 2 PM EST 🔗 Register via the QR code or this link: https://lnkd.in/eYk3xs9W Thank you to our panel for their partnership on this event: 🔹Jake Curtis: VP, Bourne Partners 🔹Harry Fisk: CFO, AmeriPro Health 🔹David Fitzgerald: Partner, Petra Capital Partners 🔹Jeanne Hecht: CEO, Lexitas Pharma Services 🔹David Stuart: Director of M&A, CREO 🔹Jim McCusker: Director of BD, CREO - Session Moderator #MergersAndAcquisitions #MA #BusinessGrowth #2025Predictions #Leadership #Webinar #LifeSciences #Healthcare #Consulting #CREO

This Black History Month, join CREO in celebrating Black innovators whose contributions have shaped science and medicine. Alice Augusta Ball was a trailblazing chemist who, at just 23, developed the first effective injectable treatment for Hansen’s disease (leprosy). The "Ball Method" was used for over 30 years, enabling countless patients to live symptom-free and amongst their communities. Ball was the first African American and the first woman to earn a master’s degree in chemistry from the University of Hawaii. Tragically, she passed away at 24 and, for years, others took credit for her work. It was not until years after her death that Ball got the credit she deserved. Today, her legacy is honored, including the designation of Alice Ball Day in Hawaii. Learn more about Alice Ball and other trailblazing scientists here: https://lnkd.in/gzrz-48f. #BlackHistoryMonth #Innovators #STEM #AliceBall

🚀 1943: the ENIAC computer—groundbreaking, but inaccessible to most. 💻 1983: the IBM PC—widely available, but lacking the right ecosystem. 🌐 1991: the worldwide web—transformative, but mainly used by tech enthusiasts. 📱 2007: the iPhone—consumer impact, but driven by one company. 🧠 2012: deep learning innovations—AI’s foundation, yet unknown to most. 🔎 And today: major players like Microsoft, Google, OpenAI, Anthropic, and others have thrown open the doors to AI for anyone with an idea. Whether you’re writing, designing, coding, or problem-solving—AI is not just for specialists anymore. 📖 How does today's AI surge stack up to past tech revolutions? And what’s next? Visit our blog to find out: https://lnkd.in/e7ew-4H9 #AIRevolution #ArtificialIntelligence #MachineLearning #TechInnovation #FutureOfAI #EmergingTech #DeepLearning

The countdown to our M&A roundtable is on! Only 8 days left to sign up for our expert-led webinar, "What's Next for M&A in 2025," on February 13. This free session will unpack key trends shaping M&A activity this year and provide actionable takeaways to help your organization thrive in an evolving landscape. Scan the QR code or follow the link to learn more about the panelists and register! ➡️ https://lnkd.in/eYk3xs9W We appreciate our panelists for their partnership on this exciting event! #MergersAndAcquisitions #MA #BusinessGrowth #2025Predictions #Leadership #Webinar #LifeSciences #Healthcare #Consulting #CREO

The day your pharmaceutical or medical device launches isn’t the finish line—it’s just the beginning. The first 18 months post-launch are critical to your product's long-term success, setting the stage for whether it thrives, survives, or fades in the market. By focusing on an agile post-launch strategy, life sciences leaders can: ✅ Establish key effectiveness indicators to track market uptake, customer retention, and engagement ✅ Adapt quickly to competitor responses with iterative strategies ✅ Fine-tune tactics across functional areas based on real-world performance A rigid launch plan can limit growth. Continuous evaluation and strategic flexibility ensure your product stays relevant, resilient, and positioned for sustainable success. Learn more in our latest blog from Akira Robinson: https://lnkd.in/e86BhvBu #ProductLaunch #LifeSciences #Agility #Strategy #LaunchStrategy #PostLaunchStrategy #Healthcare